UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical applications of the CellSearch platform in cancer patients

Advanced drug delivery reviews, 2018-02, Vol.125, p.102-121

2018

Volltextzugriff (PDF)

Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial

Clinical cancer research, 2017-09, Vol.23 (18), p.5384-5393

2017

Volltextzugriff (PDF)

Review: Biological relevance of disseminated tumor cells in cancer patients

International journal of cancer, 2008-11, Vol.123 (9), p.1991-2006

2008

Volltextzugriff (PDF)

Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer

Clinical cancer research, 2012-10, Vol.18 (20), p.5701-5710

2012

Volltextzugriff (PDF)

Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells

Annals of the New York Academy of Sciences, 2010-10, Vol.1210 (1), p.66-77

2010

Volltextzugriff (PDF)

Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells

Clinical chemistry (Baltimore, Md.), 2016-11, Vol.62 (11), p.1504-1515

2016

Volltextzugriff (PDF)

Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing

Cancer research (Chicago, Ill.), 2013-05, Vol.73 (10), p.2965-2975

2013

Volltextzugriff (PDF)

EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients

Scientific reports, 2019-05, Vol.9 (1), p.7406-7406, Article 7406

2019

Volltextzugriff (PDF)

VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors

Cancer cell, 2011-12, Vol.20 (6), p.701-714

2011

Volltextzugriff (PDF)

Capture of viable circulating tumor cells in the liver of colorectal cancer patients

Clinical chemistry (Baltimore, Md.), 2013-09, Vol.59 (9), p.1384-1392

2013

Volltextzugriff (PDF)

Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer

Clinical cancer research, 2012-11, Vol.18 (21), p.5972-5982

2012

Volltextzugriff (PDF)

Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

Clinical cancer research, 2010-05, Vol.16 (9), p.2634-2645

2010

Volltextzugriff (PDF)

Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

Clinical cancer research, 2007-02, Vol.13 (3), p.920-928

2007

Volltextzugriff (PDF)

Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis

Breast cancer research and treatment, 2014-07, Vol.146 (1), p.163-174

2014

Volltextzugriff (PDF)

Circulating Tumor Cells and Bone Marrow Micrometastasis

Clinical cancer research, 2008-08, Vol.14 (16), p.5013-5021

2008

Volltextzugriff (PDF)

Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients

Scientific reports, 2016-12, Vol.6 (1), p.39736-39736, Article 39736

2016

Volltextzugriff (PDF)

Clonality of circulating tumor cells in breast cancer brain metastasis patients

Breast cancer research : BCR, 2019-09, Vol.21 (1), p.101-101, Article 101

2019

Volltextzugriff (PDF)

Dual Roles of the Transcription Factor Grainyhead-like 2 (GRHL2) in Breast Cancer

The Journal of biological chemistry, 2013-08, Vol.288 (32), p.22993-23008

2013

Volltextzugriff (PDF)

HER2-targeted therapy influences CTC status in metastatic breast cancer

Breast cancer research and treatment, 2020-07, Vol.182 (1), p.127-136

2020

Volltextzugriff (PDF)

Characterization of different CTC subpopulations in non-small cell lung cancer

Scientific reports, 2016-06, Vol.6 (1), p.28010-28010, Article 28010

2016

Volltextzugriff (PDF)

Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer

PloS one, 2021-06, Vol.16 (6), p.e0252897-e0252897

2021

Volltextzugriff (PDF)

High-resolution analysis of Merkel Cell Polyomavirus in Merkel Cell Carcinoma reveals distinct integration patterns and suggests NHEJ and MMBIR as underlying mechanisms

PLoS pathogens, 2020-08, Vol.16 (8), p.e1008562

2020

Volltextzugriff (PDF)

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

Scientific reports, 2019-02, Vol.9 (1), p.2318-2318, Article 2318

2019

Volltextzugriff (PDF)

Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection

Oncotarget, 2017-10, Vol.8 (52), p.89978-89987

2017

Volltextzugriff (PDF)

1 – 25 von 244

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(212)

Publikationsform

Artikel
(243)
Buchkapitel
(1)

Sprache

Englisch
(243)
Deutsch
(2)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(178)
Life Sciences & Biomedicine
(164)
Humans
(140)
Female
(96)
Oncology
(94)
Tumors
(79)
Breast Cancer
(58)
Prognosis
(56)
Biological And Medical Sciences
(55)
Middle Aged
(55)
Metastasis
(51)
Medical Sciences
(50)
Aged
(48)
Neoplastic Cells, Circulating - Pathology
(46)
Circulating Tumor Cells
(44)
Male
(44)
Breast Neoplasms - Pathology
(39)
Adult
(36)
Metastases
(36)
Tumor Cells
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical applications of the CellSearch platform in cancer patients

Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant "Geparquattro" Trial

Review: Biological relevance of disseminated tumor cells in cancer patients

Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer

Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells

Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells

Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing

EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients

VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors

Capture of viable circulating tumor cells in the liver of colorectal cancer patients

Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer

Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis

Circulating Tumor Cells and Bone Marrow Micrometastasis

Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity

Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients

Clonality of circulating tumor cells in breast cancer brain metastasis patients

Dual Roles of the Transcription Factor Grainyhead-like 2 (GRHL2) in Breast Cancer

HER2-targeted therapy influences CTC status in metastatic breast cancer

Characterization of different CTC subpopulations in non-small cell lung cancer

Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer

High-resolution analysis of Merkel Cell Polyomavirus in Merkel Cell Carcinoma reveals distinct integration patterns and suggests NHEJ and MMBIR as underlying mechanisms

The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection

Suchergebnisse filtern